The Global Hereditary Angioedema Market accounted for US$ 2.70 billion in 2020 and is estimated to be US$ 6.36 billion by 2030 and is anticipated to register a CAGR of 8.9%. Herbal medicine (also herbalism) is that the study of pharmacognosy and therefore the use of medicinal plants, which are a basis of traditional medicine. There is limited scientific evidence for the security and efficacy of plants utilized in 21st century herbalism, which generally doesn’t provide standards for purity or dosage. The scope of herbal medicine commonly includes fungal and bee products, also as minerals, shells and certain animal parts. Herbal medicine is additionally called phytomedicine or phytotherapy.
The report “Global Hereditary Angioedema Market, By Drug Class (C1 Esterase Inhibitor, Kallikrein Inhibitor, Bradykinin Receptor, Attenuated Androgens, and Others), By Route of Administration (Subcutaneous, Intravenous, and Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) – Trends, Analysis and Forecast till 2030”
Key Highlights:
- In 2021, Sandoz, a global leader in generic and biosimilar medicines, announced the US launch of generic Icatibant injection pre-filled syringe to treat acute attacks of rare disease hereditary angioedema (HAE) in adults 18 years and older. It is available immediately for US patients.
Analyst View:
Growing research and development activities by key players in this market, coupled with increased support by various government and healthcare regulatory bodies operating in treatment of hereditary angioedema are major factors driving growth of the market. For instance, in 2017, the U.S. Food and Drug Administration (FDA) approved CSL Behring’s Haegarda (C1-esterase inhibitor), which is indicated for routine prophylaxis to prevent hereditary angioedema attacks in adolescent and adult patients. In September 2018, Health Canadahas authorizedShire plc’s TAKHZYRO (lanadelumab injection) for prevention of hereditary angioedema (HAE) attacks in adolescents and adults 12 years of age and older.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Hereditary Angioedema Market, By Drug Class (C1 Esterase Inhibitor, Kallikrein Inhibitor, Bradykinin Receptor, Attenuated Androgens, and Others), By Route of Administration (Subcutaneous, Intravenous, and Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) – Trends, Analysis and Forecast till 2030”
To know the upcoming trends and insights prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Global-Hereditary-Angioedema-Market-By-42
Key Market Insights from the report:
The Global Hereditary Angioedema Market accounted for US$ 2.70 billion in 2020 and is estimated to be US$ 6.36 billion by 2030 and is anticipated to register a CAGR of 8.9%. The global hereditary angioedema market has been segmented on the basis of drug class, route of administration, distribution channel, and region.
- By Drug Class, the Global Hereditary Angioedema Market is segmented into C1 Esterase Inhibitor, Kallikrein Inhibitor, Bradykinin Receptor, Attenuated Androgens, and Others.
- By Route of Administration, the Global Hereditary Angioedema Market is segmented into Subcutaneous, Intravenous, and Oral.
- By Distribution Channel, the Global Hereditary Angioedema Market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.
- By region, the Global Hereditary Angioedema Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Competitive Landscape:
Key players operating in the global hereditary angioedema market includes CSL Behring, Shire Plc., Pharming Healthcare, Inc., BioCryst Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Arrowhead Pharmaceuticals, Adverum Biotechnologies, and Attune Pharmaceuticals, Inc.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
About Prophecy Market Insights
Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.
Some Important Points Answered in this Market Report Are Given Below:
- Explains an overview of the product portfolio, including product development, planning, and positioning
- Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
- Detailed analysis of the market revenue over the forecasted period.
- Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
- Study on the segments that are anticipated to dominate the market.
- Study on the regional analysis that is expected to register the highest growth over the forecast period
Key Topics Covered
- Introduction
- Study Deliverables
- Study Assumptions
- Scope of the Study
- Research Methodology
- Executive Summary
- Opportunity Map Analysis
- Market at Glance
- Market Share (%) and BPS Analysis, by Region
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Investment Analysis
- Competitive Analysis
To know more
Contact Us:
Sales
Prophecy Market Insights
1 860 531 2701
Email- sales@prophecymarketinsights.com
